Whitehawk Therapeutics, Inc.
WHWK Nasdaq
SEC CIK 1422142
Follow Whitehawk Therapeutics
Weekly email: filings, results, news
Revenue, last quarter
$0
Net income
−$16.6M
+68.4% vs same quarter last year
EPS, diluted
−$0.20
+73.7% vs same quarter last year
Operating cash flow
−$14.5M
+72.6% vs same quarter last year
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY25 | $7.1M | −$20.6M |
| FY24 | $26M | −$63.7M |
| FY23 | $24.4M | −$65.8M |
| FY22 | $15.2M | −$60.5M |
| FY21 | $14M | −$110.1M |
| FY20 | $14M | −$3.5M |
| FY19 | $0 | −$23.3M |
| FY18 | $20.2M | −$10.4M |
| FY17 | - | −$21.4M |
| FY16 | - | −$17M |
| FY15 | - | −$31.4K |
| FY14 | - | −$30.8K |
| FY13 | - | −$28.7K |
| FY12 | - | −$27.4K |
| FY11 | - | −$27.2K |
- Gross margin
- Operating margin
- Net margin
Show the numbers
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY25 | 89.4% | −1601.1% | −288.3% |
| FY24 | 88.4% | −259.6% | −245.1% |
| FY23 | 88.5% | −295.4% | −270% |
| FY22 | 91.2% | −411.9% | −397.7% |
| FY21 | 100% | −794.4% | −786.4% |
| FY20 | - | −18.2% | −24.8% |
| FY19 | - | - | - |
| FY18 | - | −55.5% | −51.6% |
| FY17 | - | - | - |
| FY16 | - | - | - |
| FY15 | - | - | - |
| FY14 | - | - | - |
| FY13 | - | - | - |
| FY12 | - | - | - |
| FY11 | - | - | - |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY25 | −$98M |
| FY24 | −$61.2M |
| FY23 | −$63.6M |
| FY22 | −$50.1M |
| FY21 | −$22.5M |
| FY20 | −$12.7M |
| FY19 | −$24.1M |
| FY18 | −$5.8M |
| FY17 | −$18.9M |
| FY16 | −$137.8K |
| FY15 | - |
| FY14 | - |
| FY13 | - |
| FY12 | - |
| FY11 | - |
- Whitehawk Therapeutics
- Healthcare median
Show the numbers
| Year | Whitehawk Therapeutics | Healthcare median |
|---|---|---|
| FY25 | −288.3% | −40.6% |
| FY24 | −245.1% | −60.7% |
| FY23 | −270% | −97.1% |
| FY22 | −397.7% | −128.5% |
| FY21 | −786.4% | −129.2% |
| FY20 | −24.8% | −136.5% |
| FY19 | - | −133.7% |
| FY18 | −51.6% | −173.4% |
| FY17 | - | −176.7% |
| FY16 | - | −164.8% |
| FY15 | - | −183.4% |
| FY14 | - | −133% |
| FY13 | - | −88.5% |
| FY12 | - | −87.4% |
| FY11 | - | −76.3% |
News
No stories filed under Whitehawk Therapeutics yet - coverage appears here as the news feed clusters it.